Association of pretransplant glycemic controlwith posttransplant outcomes in diabetic kidney transplant recipients

Diabetes Care

Volumn 34, Issue 12, 2011, Pages 2536-2541

  Molnar, Miklos Z ^a,b   Huang, Edmund ^c   Hoshino, Junichi ^a,d   Krishnan, Mahesh ^e   Nissenson, Allen R ^c,e   Kovesdy, Csaba P ^f,g   Kalantar Zadeh, Kamyar ^a,c,d  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DAVITA INC   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; ASIAN; CAUCASIAN; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; GLYCEMIC CONTROL; GRAFT FAILURE; GRAFT SURVIVAL; HAZARD RATIO; HEMODIALYSIS; HISPANIC; HUMAN; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEGRO; PERITONEAL DIALYSIS; PREOPERATIVE EVALUATION; PROPORTIONAL HAZARDS MODEL; SEX RATIO; TREATMENT OUTCOME; CHRONIC KIDNEY FAILURE; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; METABOLISM; MIDDLE AGED; REGISTER; RENAL REPLACEMENT THERAPY; UNITED STATES;

ADULT; BLOOD GLUCOSE; DELAYED GRAFT FUNCTION; DIABETES COMPLICATIONS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; REGISTRIES; RENAL DIALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84857791539     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0906     Document Type: Article

References (25)

1. Kuo HT, Sampaio MS, Vincenti F, Bunnapradist S. Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database. Am J Kidney Dis 2010;56:1127-1139
2. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-393 (Pubitemid 36159355)
3. Warram JH, Manson JE, Krolewski AS. Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus. N Engl J Med 1995;332:1305-1306
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
5. American Diabetes Association. Standards ofmedical care in diabetes - 2010.Diabetes Care 2010;33(Suppl. 1):S11-S61
6. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005;45:S1-S153
7. WilliamsME, Lacson E Jr, TengM,Ofsthun N, Lazarus JM. Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int 2006;70:1503-1509 (Pubitemid 44527322)
8. KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49:S12-S154
9. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572 (Pubitemid 351831357)
10. Williams ME, Lacson E Jr, Wang W, Lazarus JM, Hakim R. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Coxmodel analyses.Clin J AmSocNephrol 2010;5:1595-1601
11. Ix JH. Hemoglobin A1c in hemodialysis patients: should one size fit all? Clin J Am Soc Nephrol 2010;5:1539-1541
12. Shurraw S, Majumdar SR, Thadhani R, Wiebe N, Tonelli M; Alberta Kidney Disease Network. Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis. Am J Kidney Dis 2010;55:875-884
13. Kalantar-Zadeh K, Kopple JD, Regidor DL, et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care 2007;30:1049-1055 (Pubitemid 46684623)
14. Duong U, Mehrotra R, Molnar MZ, et al. Glycemic control and survival in peritoneal dialysis patients with diabetesmellitus.Clin J Am Soc Nephrol 2011;6:1041-1048
15. Molnar MZ, Kovesdy CP, Bunnapradist S, et al. Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant 2011;11:1006-1015
16. Kovesdy CP, Park JC, Kalantar-Zadeh K. Glycemic control and burnt-out diabetes in ESRD. Semin Dial 2010;23:148-156
17. Kalantar-Zadeh K, Derose SF, Nicholas S, Benner D, Sharma K, Kovesdy CP. Burntout diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus. J Ren Nutr 2009;19:33-37
18. Menon V, Greene T, Pereira AA, et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol 2005;16:3411-3417 (Pubitemid 46179345)
19. Wu MS, Yu CC, Yang CW, et al. Poor predialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol Dial Transplant 1997;12:2105-2110
20. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003;3:178-185 (Pubitemid 36323115)
21. Burroughs TE, Swindle J, Takemoto S, et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation 2007;83:1027-1034 (Pubitemid 46659113)
22. Porrini E, Gomez MD, Alvarez A, et al. Glycated haemoglobin levels are related to chronic subclinical inflammation in renal transplant recipients without pre-existing or new onset diabetes. Nephrol Dial Transplant 2007;22:1994-1999 (Pubitemid 47244772)
23. Molnar MZ, Czira ME, Rudas A, et al. Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients. Am J Kidney Dis 2011;58:101-108
24. Cole EH, Johnston O, Rose CL, Gill JS. Impact of acute rejection and new-onset diabetes on long-termtransplant graft and patient survival. Clin J Am Soc Nephrol 2008;3:814-821
25. Mehrotra R, Kalantar-Zadeh K, Adler S. Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin? Clin J Am Soc Nephrol 2011;6:1520-1522